Cargando…
Sero-prevalence of anti-SARS-CoV-2 antibodies among communities between July and August 2022 in Bangui, Central African Republic
BACKGROUND: Large-scale population-based seroprevalence studies of SARS-CoV-2 are essential to characterize the cumulative incidence of SARS-CoV-2 infection and to extrapolate the prevalence of presumptive immunity at the population level. Objective. The objective of our survey was to estimate the c...
Autores principales: | Manirakiza, Alexandre, Malaka, Christian, Longo, Jean de Dieu, Yambiyo, Brice Martial, Diemer, Saint-Calver Henri, Namseneï, Joella, Coti-Reckoundji, Cathy Sandra Gomelle, Bouhouda, Modeste, Belizaire, Marie Roseline Darnycka, Roungou, Jean Baptiste, Komas, Narcisse Patrice, Grésenguet, Gérard, Vernet, Guy, Vernet, Marie-Astrid, Nakoune, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519115/ https://www.ncbi.nlm.nih.gov/pubmed/37753434 http://dx.doi.org/10.4081/jphia.2023.2315 |
Ejemplares similares
-
Seroprevalence of anti-SARS-CoV-2 antibodies before and after implementation of anti-COVID-19 vaccination among hospital staff in Bangui, Central African Republic
por: Manirakiza, Alexandre, et al.
Publicado: (2023) -
The prevalence of hepatitis B virus markers in a cohort of students in Bangui, Central African Republic
por: Komas, Narcisse P, et al.
Publicado: (2010) -
Clinical and epidemiological aspects of a hepatitis E outbreak in Bangui, Central African Republic
por: Goumba, Alice I, et al.
Publicado: (2011) -
Risk factors for HIV infection among female sex workers in Bangui, Central African Republic
por: Longo, Jean De Dieu, et al.
Publicado: (2017) -
Incidence and risk factors for tuberculosis among people living with HIV in Bangui: A cohort study
por: Longo, Jean De Dieu, et al.
Publicado: (2022)